PartnerFacts
Data last updated: Oct 23, 2026, 5:45 PM ETLatest filing: Oct 22, 2026Now: Oct 24, 2026, 9:49 AM ET

Sponsor Check › Person

PL
No photo found yet (own website and image search run after this page is viewed)

Paul LaViolette

Named as an officer, director or promoter on SEC Form D filings · CA, MA, NC, FL, MD, MN, NY, IL, VA, WA · Feb 24, 2011 → Jul 23, 2026

20deals (issuers)
$1.5Breported sold
674investors
70Form D filings
2011–2026years on file
Follow this personLook further ↓PDF

Data last updated Oct 23, 2026, 5:45 PM ET · Courts (RECAP) last checked: Oct 24, 2026, 2:23 AM ET · SEC enforcement last checked: covered by the index scan as of Oct 24, 2026, 2:50 AM ET

The short version

Paul LaViolette is listed as an executive officer and director on 70 SEC Form D filings by 20 issuers between Oct 2009 and Jul 2026. Largest by amount reported sold: SV Life Sciences Fund IV CF, L.P. (Boston, MA — pooled investment fund — 2022; $421.4M reported sold to 44 investors), SV Life Sciences Fund VI, L.P. (Boston, MA — pooled investment fund — 2015–2016; $273.5M reported sold to 24 investors), TRANSENTERIX INC. (Morrisville, NC — other health care — 2013–2017; $160.4M reported sold to 43 investors), Cameron Health, Inc. (San Clemente, CA — other health care — 2011; $82.7M reported sold to 62 investors), Axon Therapies Inc. (New York, NY — other technology — 2016–2019; $75M reported sold to 10 investors) and 15 more (all listed below).

What this means That is a lot of deals — 20 separate companies raised money with this person listed as executive officer and director, over about 17 years. Across those companies the filings report $1.5B sold in total.

Listed alongside Bruce Robertson (12 shared filings), Gerry Brunk (11 shared filings), Charles Larsen (10 shared filings), CHRISTOPHER A. KROEGER (9 shared filings), James Garvey (9 shared filings) and 176 others.

What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Paul. Each name links to their own page.

The issuers belong to 3 sponsor groups: Sv Life Sciences (10 issuers, $1.56B reported sold, 2010–2026), Bardy (2 issuers, $10.5M reported sold, 2016–2025) and Transenterix (2 issuers, $2.95M reported sold, 2009–2017).

What this means This person is listed across more than one sponsor team; each group page shows that team's full track record.

Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AK, AL, AR, AZ, CA, CO, CT, DC, DE, FINRA, FL, GA, HI, ID, IL, KS, KY, LA, MA, MD, ME, MI, MO, MS, MT, NASAA, NC, ND, NH, NM, NV, NY, OH, OK, OR, PA, RI, SC, SD, TN, TX, UT, VT, WA, WI, WV, WY) — 3 bankruptcy cases matching the name listed in Key records below.

What this means 3 records came back. Each one is listed below with a link to the original document and a line saying why it matched. A name match is not proof it is the same person or company — read the why line and the document. Being sued or named in a release is an accusation, not a finding.

We compared the newest 50 of 70 public filings for Paul LaViolette and found 15 differences, 3 worth asking the sponsor about: 5 bankruptcy cases name the subject or team members; Amount sold went down between filings; and more below.

What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.

What the community is saying

Community search for Paul LaViolette has not run yet — it is #10,302 of 41,711 in line; searches run around the clock at the hosts' allowed rate. Searched so far: 641 names.

Community comments are quoted as written by their authors. Sources searched: Bing (site:reddit.com / site:biggerpockets.com) and Reddit's own search, plus DuckDuckGo/Brave/BiggerPockets search when they are answering.

Key records

Five things investors ask first. Items still in human review are counted, not shown.

1. Lawsuits

None found in sources searched — federal courts (CourtListener / RECAP), checked Oct 24, 2026

What was searched

Sources searched: CourtListener bulk data (RECAP dockets as of 2026-09-30; recall-first rule 10-24) — federal district + bankruptcy courts State courts: not covered (one-tap state court links under Look further). PACER: not searched. · Last checked Oct 24, 2026, 2:23 AM ET.

State courts: not covered (one-tap state court links under Look further). No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.

2. Regulatory actions

None found in sources searched — SEC enforcement releases (index scan as of Oct 24, 2026, 2:50 AM ET) · state securities regulators: 48 regulators (FINRA, NASAA, 37 states) — crawled Oct 24, 2026, 8:48 AM ET

What was searched

SEC enforcement searched: SEC litigation releases and administrative proceedings — respondent names in the sec.gov index titles (30,205 releases, 1995-09-19 to 2026-10-23); release text is read only to confirm a candidate. Names that appear only in the body of a release are not found. — Searched SEC litigation releases and administrative proceedings (1995→ / 2007→) (30,205 records as of Oct 24, 2026, 2:50 AM ET) — nothing matched Paul LaViolette..

State securities regulators: Securities regulators searched (64,910 actions): FINRA (38,350 actions, 1995–2026), NASAA (31 actions, 2000–2026; listing starts 1997), AK Division of Banking and Securities (273 actions, 1971–2025), AL Securities Commission (880 actions, 2001–2026), AR Securities Department (1,305 actions, 1998–2026), AZ Corporation Commission Securities Division (411 actions, 2017–2026), CA DFPI (25 actions, 2007–2024; listing starts 2002 — 16 of 12,159 DFPI respondent pages read so far; sponsor-name matches are read first), CO Division of Securities (731 actions, 2001–2026; older years from the Internet Archive (snapshot of 2026-05-02)), CT Department of Banking Securities Division (940 actions, 2006–2026; older years from the Internet Archive (snapshot of 2026-04-22)), DC DISB Securities Bureau (25 actions, 2012–2026), DE DOJ Investor Protection Unit (257 actions, 1987–2026), FL Office of Financial Regulation (49 actions, 2018–2026), GA Secretary of State Securities Division (65 actions, 2015–2026; listing starts 2012), HI DCCA Securities Enforcement Branch (26 actions, 2012–2026), ID Department of Finance Securities Bureau (663 actions, 1994–2026), IL Secretary of State Securities Department (4,122 actions, 2003–2023), KS Insurance Department Securities Division (58 actions), KY Department of Financial Institutions (342 actions, 2005–2026), LA Office of Financial Institutions Securities Division (13 actions, 2010–2025; listing starts 2008), MA Secretary of the Commonwealth Securities Division (125 actions, 2012–2025; live site blocks automated access — loaded from the Internet Archive snapshot of 2026-02-04), MD Attorney General Securities Division (1,054 actions, 2004–2026), ME Office of Securities (539 actions, 2000–2026), MI LARA Corporations, Securities & Commercial Licensing Bureau (201 actions), MO Secretary of State Securities Division (919 actions, 1998–2026), MS Secretary of State Securities Division (209 actions, 1995–2026), MT Commissioner of Securities and Insurance (597 actions, 2000–2026), NC Secretary of State Securities Division (265 actions, 2004–2024), ND Securities Department (711 actions, 1990–2026; the regulator no longer publishes this list live — loaded from the Internet Archive snapshot of 2026-01-06), NH Bureau of Securities Regulation (402 actions, 2002–2026), NM Regulation and Licensing Department Securities Division (90 actions, 2010–2025), NV Secretary of State Securities Division (118 actions, 2018–2026), NY Attorney General Investor Protection Bureau (44 actions, 2012–2026), OH Division of Securities (327 actions, 1993–2006), OK Department of Securities (2,531 actions, 1998–2026), OR Division of Financial Regulation (589 actions, 1988–2026), PA Department of Banking and Securities (1,448 actions, 2008–2024; the regulator no longer publishes this list live — loaded from the Internet Archive snapshot of 2024-08-09), RI DBR Securities Division (98 actions, 2005–2025), SC Attorney General Securities Division (540 actions, 2006–2026), SD Division of Insurance – Securities Regulation (106 actions, 2017–2026), TN Department of Commerce and Insurance Securities Division (405 actions, 1992–2026), TX State Securities Board (936 actions, 1999–2026), UT Division of Securities (772 actions, 2000–2026; older years from the Internet Archive (snapshot of 2010-05-27)), VT DFR Securities Division (137 actions, 2010–2026), WA DFI (2,039 actions, 2001–2026), WI DFI Division of Securities (1,072 actions, 1998–2026), WV Securities Commission (State Auditor) (64 actions), WY Secretary of State Compliance Division (6 actions, 2016–2024) — last crawled Oct 24, 2026, 8:48 AM ET. No machine-readable public listing today for IA, IN, MN, NE, NJ, VA (see docs/state-regulators.md).

3. Bankruptcies

3 cases: 3 closed (disposition not in docket feed)

Donna L. Laviolette and Paul J. Laviolette closed
United States Bankruptcy Court, D. Massachusetts · No. 11-41643 · Filed Apr 22, 2011 · Closed Aug 2, 2011
Role of Paul J. Laviolette: Debtor · Outcome: Case closed 2011-08-02 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗
same full name (rare in federal dockets); 2 people with this name in Form D filings; court in the person's filing state (MA)
Paul J. LaViolette closed
United States Bankruptcy Court, D. Massachusetts · No. 02-45898 · Filed Sep 26, 2002 · Closed Nov 4, 2002
Role of Paul J. LaViolette: Debtor · Outcome: Case closed 2002-11-04 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗
same full name (rare in federal dockets); 2 people with this name in Form D filings; court in the person's filing state (MA)
Paul J. LaViolette and Donna L. LaViolette closed
United States Bankruptcy Court, D. Massachusetts · No. 94-42291 · Filed May 17, 1994 · Closed Aug 26, 1994
Role of Paul J. LaViolette and Donna L. LaViolette: Debtor · Outcome: Case closed 1994-08-26 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗
same full name (rare in federal dockets); 2 people with this name in Form D filings; court in the person's filing state (MA)
What was searched

Sources searched: Federal bankruptcy courts via CourtListener / RECAP archive (federal district courts, federal bankruptcy courts). State courts: not covered (one-tap state court links under Look further). PACER: not searched (RECAP only). · Last checked Oct 24, 2026, 2:23 AM ET.

Court records show docket facts only; we never restate allegations as facts. Outcome wording comes from the docket feed; where it does not state a disposition we say so.

State courts: not covered (one-tap state court links under Look further). No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.

4. Differences between public sources

Comparisons cover issuers and sponsor groups — see the issuer pages under Deals

15 differences found between the filings for Paul LaViolette — 3 worth asking about (compared the newest 50 of 70 filings on Oct 24, 2026; older filings not covered)

Worth asking · May 17, 1994 – Aug 2, 2011

5 bankruptcy cases name the subject or team members

Bankruptcy case: Donna L. Laviolette and Paul J. Laviolette — filed Apr 22, 2011 · Bankruptcy case: Paul J. LaViolette — filed Sep 26, 2002 · Bankruptcy case: Paul J. LaViolette and Donna L. LaViolette — filed May 17, 1994 · Bankruptcy case: Michael E. Anderson and Bardy L. Anderson — filed May 5, 1999 · Bankruptcy case: AFBA Industrial Bank v. Neustaedter — filed Mar 28, 1997

What this means A bankruptcy filing was found. Many are old or personal and have nothing to do with the deal — but ask what it was and when it closed.

Docket · United States Bankruptcy Court, D. Massachusetts ↗Docket · United States Bankruptcy Court, D. Massachusetts ↗Docket · United States Bankruptcy Court, D. Massachusetts ↗Docket · United States Bankruptcy Court, S.D. California ↗
Sources
Worth asking · Feb 7, 2019

Amount sold went down between filings — Axon Therapies Inc.

The Feb 7, 2019 filing says $74,999,993 sold; the Feb 7, 2019 Form D/A says $7,499,994 sold — $67,499,999 less.

What this means Amounts sold normally only go up as a raise continues. A drop can mean investors were refunded, a figure was corrected, or an earlier number was wrong. Ask the sponsor which it was.

Form D (earlier) · Feb 7, 2019 ↗Form D/A (later) · Feb 7, 2019 ↗Axon Therapies Inc. — PartnerFacts page ↗
Sources
Note · Feb 7, 2019 – Mar 12, 2019

Paul LaViolette appears on 2 deals that stopped filing before reaching their target

Medtech Convergence Fund, L.P. (last filing Mar 12, 2019; $0 sold of $94,000,000); Axon Therapies Inc. (last filing Feb 7, 2019; $74,999,993 sold of $150,000,000). Each has no filing in more than two years and reported under half its target sold.

What this means An issuer whose last filing is more than two years old and reported under half its target sold. The raise may have closed early or quietly stopped. Ask what happened to each.

Medtech Convergence Fund, L.P. — PartnerFacts page ↗Axon Therapies Inc. — PartnerFacts page ↗
Sources
Worth asking · Jul 25, 2018 – Jul 23, 2026

6 Form Ds were filed more than 15 days after the first sale

Form D filed 224 days after the first sale — SV Life Sciences Fund IV CF, L.P. · Form D filed 45 days after the first sale — CSA Medical, Inc. · Form D filed 40 days after the first sale — Lunair Medical, Inc. · Form D filed 19 days after the first sale — CSA Medical, Inc. · Form D filed 18 days after the first sale — VALENTX INC · and 1 more

What this means Late notices are common and carry no penalty by themselves. A pattern of late paperwork is worth asking the sponsor about.

Form D · Mar 25, 2022 ↗SV Life Sciences Fund IV CF, L.P. — PartnerFacts page ↗Form D · Jul 23, 2026 ↗CSA Medical, Inc. — PartnerFacts page ↗
Sources
Note · Sep 12, 2014 – Sep 15, 2025

28 offerings have no amendment in the last 12 months and may still be open

No amendment in the last 12 months on an offering that may still be open — Lunair Medical, Inc. (latest filing Sep 15, 2025) · No amendment in the last 12 months on an offering that may still be open — Corvia Medical, Inc. (latest filing Jun 25, 2025) · No amendment in the last 12 months on an offering that may still be open — SpectraWAVE, Inc. (latest filing Oct 15, 2024) · No amendment in the last 12 months on an offering that may still be open — CSA Medical, Inc. (latest filing Sep 18, 2024) · No amendment in the last 12 months on an offering that may still be open — CardioFocus, Inc. (latest filing Apr 12, 2022) · and 23 more

What this means SEC rules expect a yearly amendment while an offering is still going. Ask the sponsor which of these raises have closed.

Form D · Sep 15, 2025 ↗Lunair Medical, Inc. — PartnerFacts page ↗Form D · Jun 25, 2025 ↗Corvia Medical, Inc. — PartnerFacts page ↗
Sources
Note · Apr 18, 2018 – May 20, 2019

Paul LaViolette's role changed at CardioFocus, Inc.: executive officer, director → director

The Apr 18, 2018 filing lists Paul LaViolette as executive officer, director; the May 20, 2019 Form D lists director.

What this means Roles on Form D are self-reported by the issuer. A change can mean a real change in who runs the company, or just a different box ticked. Ask who makes decisions today.

Form D · Apr 18, 2018 ↗Form D · May 20, 2019 ↗Paul LaViolette — PartnerFacts page ↗CardioFocus, Inc. — PartnerFacts page ↗
Sources
Note · May 18, 2016 – Mar 1, 2017

Paul LaViolette's role changed at CardioFocus, Inc.: director → executive officer, director

The May 18, 2016 filing lists Paul LaViolette as director; the Mar 1, 2017 Form D lists executive officer, director.

What this means Roles on Form D are self-reported by the issuer. A change can mean a real change in who runs the company, or just a different box ticked. Ask who makes decisions today.

Form D · May 18, 2016 ↗Form D · Mar 1, 2017 ↗Paul LaViolette — PartnerFacts page ↗CardioFocus, Inc. — PartnerFacts page ↗
Sources
Note · Dec 5, 2014 – Dec 7, 2020

7 offerings changed their target amount between filings

Offering amount changed between filings — ENDOTRONIX INC · Offering amount changed between filings — ENDOTRONIX INC · Offering amount lowered between filings — Axon Therapies Inc. · Offering amount changed between filings — Bardy Diagnostics, Inc. · Offering amount changed between filings — ENDOTRONIX INC · and 2 more

What this means Targets change as deals grow or shrink. Ask whether later money has the same terms.

Form D/A (earlier) · Oct 16, 2019 ↗Form D/A (later) · Dec 7, 2020 ↗ENDOTRONIX INC — PartnerFacts page ↗Form D (earlier) · Sep 28, 2018 ↗
Sources
Note · Jul 1, 2014 – Jul 28, 2014

Paul LaViolette is written 2 different ways on the filings

listed as "Paul LaViolette" on 49 filings (from Jul 1, 2014), and "Paul A. Laviolette" on 4 filings (from Jul 28, 2014).

What this means Same person, written differently — a middle name or suffix left off, or spelled another way. It is normal, but check that the full legal name matches your subscription documents.

Form D · Jul 1, 2014 ↗Form D · Jul 28, 2014 ↗Paul LaViolette — PartnerFacts page ↗
Sources
Note · May 18, 2016 – Jul 20, 2020

Industry group changed between filings — CardioFocus, Inc.

"Biotechnology" (May 18, 2016 to May 20, 2019); then "Other Technology" (Jul 20, 2020 to Apr 12, 2022).

What this means The issuer described its business differently on different forms. Often it is just a different box ticked; sometimes the deal itself changed. Ask which business your money is in.

Form D · May 18, 2016 ↗Form D · Jul 20, 2020 ↗CardioFocus, Inc. — PartnerFacts page ↗
Sources
Note · Sep 14, 2020 – Sep 15, 2020

Same name, different state: "Paul Laviolette" (FL) is a separate record

This page covers filings where the address state is CA or MA or NC or FL or MD or MN or NY or IL or VA or WA. A separate record, "Paul Laviolette" with address state FL, is listed on 2 filings — most recently by Stimwave Technologies Inc (Sep 15, 2020). Both records have filings in the same period (Sep 14, 2020 to Sep 15, 2020).

What this means Two records with one name were active at the same time. That can be one person listing different company addresses, or two different people. We keep them apart until a filing ties them together. Check both pages before you decide.

Paul Laviolette (FL) — PartnerFacts page ↗Form D · Sep 15, 2020 ↗Stimwave Technologies Inc — PartnerFacts page ↗Paul LaViolette (CA,MA,NC,FL,MD,MN,NY,IL,VA,WA) — this page ↗
Sources
Note · Oct 12, 2016 – Jun 8, 2018

Address moved from Charlotte, NC to Seattle, WA — Bardy Diagnostics, Inc.

The people listed on the Oct 12, 2016 filing give Charlotte, NC; on the Jun 8, 2018 filing they give Seattle, WA.

What this means Businesses move; this just shows the two places and dates. If you were told one city and the forms say another, ask which is current.

Form D · Oct 12, 2016 ↗Form D/A · Jun 8, 2018 ↗Bardy Diagnostics, Inc. — PartnerFacts page ↗
Sources
Note · Jul 19, 2016 – Feb 26, 2018

Address moved from Woodridge, IL to Lisle, IL — ENDOTRONIX INC

The people listed on the Jul 19, 2016 filing give Woodridge, IL; on the Feb 26, 2018 filing they give Lisle, IL.

What this means Businesses move; this just shows the two places and dates. If you were told one city and the forms say another, ask which is current.

Form D · Jul 19, 2016 ↗Form D/A · Feb 26, 2018 ↗ENDOTRONIX INC — PartnerFacts page ↗
Sources
Note · Jul 13, 2015 – Dec 5, 2016

Address moved from Lutherville, MD to Lexington, MA — CSA Medical, Inc.

The people listed on the Jul 13, 2015 filing give Lutherville, MD; on the Dec 5, 2016 filing they give Lexington, MA.

What this means Businesses move; this just shows the two places and dates. If you were told one city and the forms say another, ask which is current.

Form D · Jul 13, 2015 ↗Form D · Dec 5, 2016 ↗CSA Medical, Inc. — PartnerFacts page ↗
Sources
Note · Jul 1, 2014 – Jul 23, 2026

Paul LaViolette is listed with 9 different address states: MA, MN, CA, MD, NY, IL, NC, VA, WA

MA on 21 filings (Jul 1, 2014 to Jul 23, 2026); MN on 5 filings (Jul 28, 2014 to Sep 15, 2025); CA on 7 filings (Dec 5, 2014 to Oct 21, 2021); MD on 2 filings (Jul 13, 2015 to Jul 13, 2015); NY on 4 filings (Apr 19, 2016 to Feb 7, 2019); IL on 5 filings (Jul 19, 2016 to Dec 7, 2020); NC on 3 filings (Sep 23, 2016 to Sep 15, 2017); VA on 1 filing (Nov 9, 2017); WA on 5 filings (Jun 8, 2018 to Mar 31, 2020).

What this means The address on a Form D is usually the company's, not the person's home, so this often just reflects different companies. It can also mean a move. Nothing wrong by itself.

Form D · Jul 1, 2014 ↗Form D · Jul 28, 2014 ↗Form D · Dec 5, 2014 ↗Form D · Jul 13, 2015 ↗
Sources
What is compared

What is compared: every Form D and D/A we hold for this subject, side by side — filing dates vs. first-sale dates (the 15-day rule), amendment timing on open offerings (the yearly-amendment expectation), amounts sold, investor counts, offering amounts and minimums across amendments, industry and size bands, addresses, how each person's name and role is written, paid sellers' CRD numbers, and (for groups) where the member companies were formed and sit. Everything is as filed by the issuer; the SEC does not check it. Differences are common and usually have ordinary explanations — we show both values, the dates, and the source so you can ask. We compared the newest 50 of 70 filings (work cap); older filings are not covered here. As of Oct 24, 2026.

5. Money to insiders

4 of 57 offerings report sales commissions totalling $2,483,557; 1 reports finder's fees totalling $1,750,000; 0 report proceeds to related persons. (includes amounts the issuer reported as estimates)

Offering (latest filing)Sales commissionsFinder's feesTo insidersPaid to sell itSource
Jul 23, 2026 D
CSA Medical, Inc.
File 021-591980
$0$0$0None listed on this filingEDGAR ↗
Sep 15, 2025 D
Lunair Medical, Inc.
File 021-557549
$0$0$0 (est.)
Excludes standard compensation for officers and directors.
None listed on this filingEDGAR ↗
Jun 25, 2025 D
Corvia Medical, Inc.
File 021-549840
$0$0$0None listed on this filingEDGAR ↗
Oct 15, 2024 D/A
SpectraWAVE, Inc.
File 021-523760
$0$0$0None listed on this filingEDGAR ↗
Sep 18, 2024 D
CSA Medical, Inc.
File 021-524381
$0$0$0None listed on this filingEDGAR ↗
Apr 12, 2022 D
CardioFocus, Inc.
File 021-441471
$0$0$0None listed on this filingEDGAR ↗
Mar 25, 2022 D
SV Life Sciences Fund IV CF, L.P.
File 021-438954
$0$0$0
An affiliate of the general partner of the Issuer will receive a management fee payable by the Issuer quarterly in advance at an annual rate as specified in the Issuer's partnership agreement.
None listed on this filingEDGAR ↗
Oct 21, 2021 D
Zerigo Health, Inc.
File 021-417986
$0$0$0None listed on this filingEDGAR ↗
Jan 25, 2021 D
Corvia Medical, Inc.
File 021-387203
$0$0$0None listed on this filingEDGAR ↗
Dec 7, 2020 D/A
ENDOTRONIX INC
File 021-322392
$0$0$0None listed on this filingEDGAR ↗
Jul 20, 2020 D
CardioFocus, Inc.
File 021-371368
$0$0$0None listed on this filingEDGAR ↗
Mar 31, 2020 D
Bardy Diagnostics, Inc.
File 021-364048
$0$0$0None listed on this filingEDGAR ↗
Feb 28, 2020 D
Bardy Diagnostics, Inc.
File 021-361629
$0$0$0None listed on this filingEDGAR ↗
Nov 15, 2019 D/A
Zerigo Health, Inc.
File 021-334344
$24,000$0$0IFS Securities BrokerCheck CRD 40375 ↗EDGAR ↗
Nov 6, 2019 D
Zerigo Health, Inc.
File 021-352681
$0$0$0None listed on this filingEDGAR ↗
May 20, 2019 D
CardioFocus, Inc.
File 021-339933
$0$0$0None listed on this filingEDGAR ↗
Apr 25, 2019 D
Bardy Diagnostics, Inc.
File 021-338120
$0$0$0None listed on this filingEDGAR ↗
Mar 12, 2019 D
Medtech Convergence Fund, L.P.
File 021-334664
$0$0$0 (est.)
An affiliate of the General Partner will receive a fee for management services. The fee will equal a percentage of aggregate subscriptions of the Issuer's limited partners.
None listed on this filingEDGAR ↗
Feb 19, 2019 D
VALENTX INC
File 021-333067
$0$0$0None listed on this filingEDGAR ↗
Feb 7, 2019 D/A
Axon Therapies Inc.
File 021-332379
$0$0$0None listed on this filingEDGAR ↗
Jan 3, 2019 D
Bardy Diagnostics, Inc.
File 021-329573
$0$0$0None listed on this filingEDGAR ↗
Aug 16, 2018 D
VALENTX INC
File 021-319415
$0$0$0None listed on this filingEDGAR ↗
Jun 8, 2018 D/A
Bardy Diagnostics, Inc.
File 021-272267
$0$0$0None listed on this filingEDGAR ↗
Apr 18, 2018 D/A
CardioFocus, Inc.
File 021-310429
$260,000$0$0TRUMP SECURITIES LLC BrokerCheck CRD 47107 ↗EDGAR ↗
Feb 26, 2018 D/A
ENDOTRONIX INC
File 021-267289
$0$0$0None listed on this filingEDGAR ↗
Nov 9, 2017 D
Soluble Systems LLC
File 021-298446
$1,500,000$0$0
In the ordinary course of business, the Issuer may use some of the proceeds of the offering to pay salaries to certain of its executive officers and directors.
Canaccord Genuity Inc. BrokerCheck CRD 1020 ↗EDGAR ↗
Sep 15, 2017 D
TRANSENTERIX INC.
File 021-294869
$0$0$0None listed on this filingEDGAR ↗
Jun 28, 2017 D
Axon Therapies Inc.
File 021-289607
$0$0$0None listed on this filingEDGAR ↗
Apr 12, 2017 D
SV Life Sciences Fund VI Strategic Partners, L.P.
File 021-284644
$0$0$0
An affiliate of the general partner of the Issuer will receive a management fee payable by the Issuer quarterly in advance at an annual rate as specified in the Issuer's partnership agreement.
None listed on this filingEDGAR ↗
Mar 1, 2017 D
CardioFocus, Inc.
File 021-281521
$0$0$0None listed on this filingEDGAR ↗
Dec 5, 2016 D
CSA Medical, Inc.
File 021-275632
$0$0$0None listed on this filingEDGAR ↗
Sep 23, 2016 D
TRANSENTERIX INC.
File 021-271229
$0$0$0None listed on this filingEDGAR ↗
Jul 22, 2016 D/A
Direct Flow Medical, Inc.
File 021-260400
$0$0$0None listed on this filingEDGAR ↗
May 26, 2016 D/A
SV Life Sciences Fund VI, L.P.
File 021-240550
$0$0$0 (est.)
An affiliate of the general partner of the Issuer will receive a management fee payable by the Issuer quarterly in advance as specified in the Issuer's partnership agreement.
Crito Capital LLC BrokerCheck CRD 161724 ↗EDGAR ↗
May 18, 2016 D
CardioFocus, Inc.
File 021-263388
$0$0$0None listed on this filingEDGAR ↗
Apr 19, 2016 D
Axon Therapies Inc.
File 021-261599
$0$0$0None listed on this filingEDGAR ↗
Apr 14, 2016 D/A
Direct Flow Medical, Inc.
File 021-229506
$0$0$0None listed on this filingEDGAR ↗
Sep 22, 2015 D/A
Corvia Medical, Inc.
File 021-220190
$0$0$0None listed on this filingEDGAR ↗
Sep 3, 2015 D/A
VALENTX INC
File 021-221854
$0$0$0None listed on this filingEDGAR ↗
Jul 13, 2015 D
CSA Medical, Inc.
File 021-243579
$0$0$0None listed on this filingEDGAR ↗
Jul 13, 2015 D
CSA Medical, Inc.
File 021-243590
$0$0$0None listed on this filingEDGAR ↗
Apr 16, 2015 D
CSA Medical, Inc.
File 021-238158
$0$0$0None listed on this filingEDGAR ↗
Jan 6, 2015 D
CardioFocus, Inc.
File 021-231462
$0$0$0None listed on this filingEDGAR ↗
Dec 9, 2014 D
CARDIOKINETIX INC
File 021-229697
$0$0$0None listed on this filingEDGAR ↗
Nov 13, 2014 D
CardioFocus, Inc.
File 021-228262
$0$0$0None listed on this filingEDGAR ↗
May 9, 2014 D
CardioFocus, Inc.
File 021-217105
$0$0$0None listed on this filingEDGAR ↗
Mar 26, 2014 D
BAXANO SURGICAL, INC.
File 021-214283
$699,557$0$0PIPER JAFFRAY & CO. BrokerCheck CRD 665 ↗
STIFEL, NICOLAUS & COMPANY, INC. BrokerCheck CRD 793 ↗		EDGAR ↗
Jan 3, 2014 D
CSA Medical, Inc.
File 021-209186
$0$0$0None listed on this filingEDGAR ↗
Dec 17, 2013 D
BAXANO SURGICAL, INC.
File 021-208130
$0$0$0None listed on this filingEDGAR ↗
Sep 17, 2013 D
TRANSENTERIX INC.
File 021-202985
$0$1,750,000$0Perella Weinberg Partners BrokerCheck CRD 138618 ↗EDGAR ↗
Sep 12, 2013 D
TRANSENTERIX INC.
File 021-202762
$0$0$0None listed on this filingEDGAR ↗
Jun 12, 2013 D
BAXANO SURGICAL, INC.
File 021-197874
$0$0$0None listed on this filingEDGAR ↗
Mar 15, 2013 D
Corvia Medical, Inc.
File 021-193422
$0$0$0None listed on this filingEDGAR ↗
Apr 17, 2012 D/A
Direct Flow Medical, Inc.
File 021-67186
$0$0$0None listed on this filingEDGAR ↗
Sep 26, 2011 D
CARDIOKINETIX INC
File 021-166380
$0$0$0None listed on this filingEDGAR ↗
May 20, 2011 D
Cameron Health, Inc.
File 021-160157
$0$0$0None listed on this filingEDGAR ↗
Feb 24, 2011 D
CardioFocus, Inc.
File 021-155798
$0$0$0None listed on this filingEDGAR ↗
How this is counted

Counts come from Form D Items 12–15 on the filings in our index (latest filing per offering; one offering = one SEC file number; an amendment updates its offering rather than adding one). "To insiders" = gross proceeds used for payments to executive officers, directors or promoters. "—" = not reported on that filing. Amounts marked (est.) were reported as estimates. "Paid to sell it" = sales compensation recipients named on that filing (Item 12), each linked to FINRA BrokerCheck when a CRD number is reported.

Counted across every filing this person is listed on (latest filing per offering, per issuer).

Deals 20

Every issuer that named Paul LaViolette on a Form D, newest first. A Form D is the notice a company files after it starts selling a private investment.

CM
Other

CSA Medical, Inc.

Lexington, MA · Jan 3, 2014 → Jul 23, 2026 · 7 filings
  • Jul 23, 2026 · D · $2,908,295 sold of $11,217,710 · 40 investors · min. No minimum reported · role: Director EDGAR ↗
  • Sep 18, 2024 · D · $59,663,552 sold of $71,158,453 · 52 investors · min. No minimum reported · role: Director EDGAR ↗
  • Dec 5, 2016 · D · $2,900,000 sold of $7,717,389 · 9 investors · min. No minimum reported · role: Director EDGAR ↗
  • Jul 13, 2015 · D · $6,564,801 sold of $6,577,923 · 26 investors · min. No minimum reported · role: Director EDGAR ↗
  • Jul 13, 2015 · D · $299,999 sold of $299,999 · 1 investors · min. No minimum reported · role: Director EDGAR ↗
  • Apr 16, 2015 · D · $2,927,303 sold of $3,938,000 · 30 investors · min. No minimum reported · role: Director EDGAR ↗
  • Jan 3, 2014 · D · $16,000,000 sold of $16,000,000 · 8 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $59.7M from 52 investors (100% of the $11.2M target) as of the latest filing. Paul is listed as director on 7 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Other / 506(b) (18,678 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

LM
Other Health Care

Lunair Medical, Inc.

Minneapolis, MN · Sep 15, 2025
  • Sep 15, 2025 · D · $7,500,000 sold of $12,500,000 · 3 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $7.5M from 3 investors (60% of the $12.5M target) as of the latest filing. Paul is listed as director.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Other Health Care / 506(b) (4,189 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

CM
Biotechnology

Corvia Medical, Inc.

Tewksbury, MA · Mar 15, 2013 → Jun 25, 2025 · 5 filings
  • Jun 25, 2025 · D · $8,860,552 sold of $11,087,670 · 10 investors · min. No minimum reported · role: Director EDGAR ↗
  • Jan 25, 2021 · D · $6,265,647 sold of $13,115,114 · 25 investors · min. No minimum reported · role: Director EDGAR ↗
  • Sep 22, 2015 · D/A · $34,000,001 sold of $34,000,001 · 9 investors · min. No minimum reported · role: Director EDGAR ↗
  • Jul 1, 2014 · D · $17,050,000 sold of $34,000,001 · 9 investors · min. No minimum reported · role: Director EDGAR ↗
  • Mar 15, 2013 · D · $10,736,836 sold of $10,736,836 · 10 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $34M from 25 investors (100% of the $11.1M target) as of the latest filing. Paul is listed as director on 5 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

S
Other

SpectraWAVE, Inc.

Bedford, MA · Sep 11, 2024 → Oct 15, 2024 · 2 filings
  • Oct 15, 2024 · D/A · $50,287,666 sold of $50,287,674 · 33 investors · min. No minimum reported · role: Director EDGAR ↗
  • Sep 11, 2024 · D · $49,312,671 sold of $50,287,674 · 26 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $50.3M from 33 investors (100% of the $50.3M target) as of the latest filing. Paul is listed as director on 2 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Other / 506(b) (18,678 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

C
Other Technology

CardioFocus, Inc.

Marlborough, MA · Feb 24, 2011 → Apr 12, 2022 · 11 filings
  • Apr 12, 2022 · D · $3,999,998 sold of $49,999,998 · 12 investors · min. No minimum reported · role: Director EDGAR ↗
  • Jul 20, 2020 · D · $12,020,000 sold of $15,000,000 · 13 investors · min. $10,000 · role: Director EDGAR ↗
  • May 20, 2019 · D · $8,000,000 sold of $12,000,000 · 17 investors · min. No minimum reported · role: Director EDGAR ↗
  • Apr 18, 2018 · D/A · $13,000,000 sold of $21,000,000 · 1 investors · min. No minimum reported · role: Executive Officer, Director EDGAR ↗
  • Apr 18, 2018 · D · $13,000,000 sold of $21,000,000 · 1 investors · min. No minimum reported · role: Executive Officer, Director EDGAR ↗
  • Mar 1, 2017 · D · $20,178,554 sold of $32,060,261 · 26 investors · min. No minimum reported · role: Executive Officer, Director EDGAR ↗
  • May 18, 2016 · D · $8,000,000 sold of $12,000,000 · 0 investors · min. No minimum reported · role: Director EDGAR ↗
  • Jan 6, 2015 · D · $31,652,646 sold of $33,200,654 · 32 investors · min. No minimum reported · role: Executive Officer, Director EDGAR ↗
  • Nov 13, 2014 · D · $2,300,000 sold of $2,300,000 · 29 investors · min. No minimum reported · role: Director EDGAR ↗
  • May 9, 2014 · D · $2,378,923 sold of $5,000,000 · 27 investors · min. No minimum reported · role: Executive Officer, Director EDGAR ↗
  • Feb 24, 2011 · D · $13,639,082 sold of $15,639,082 · 25 investors · min. $2,000 · role: Director EDGAR ↗

Raised $31.7M from 32 investors (63% of the $50M target) as of the latest filing. Paul is listed as director, executive officer on 11 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Other Technology / 506(b) (17,390 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

SL
Pooled Investment Fund · group: Sv Life Sciences

SV Life Sciences Fund IV CF, L.P.

Boston, MA · Mar 25, 2022
  • Mar 25, 2022 · D · $421,446,223 sold of $421,446,223 · 44 investors · min. No minimum reported · role: Executive Officer EDGAR ↗

Raised $421.4M from 44 investors (100% of the $421.4M target) as of the latest filing. Paul is listed as executive officer.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pooled Investment Fund / 506(b) (83,801 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

ZH
Other Health Care

Zerigo Health, Inc.

San Diego, CA · Nov 6, 2019 → Oct 21, 2021 · 3 filings
  • Oct 21, 2021 · D · $42,999,084 sold of $42,999,084 · 15 investors · min. No minimum reported · role: Director EDGAR ↗
  • Nov 15, 2019 · D/A · $2,606,762 sold of $3,000,300 · 12 investors · min. No minimum reported · role: Director EDGAR ↗
  • Nov 6, 2019 · D · $15,787,828 sold of $21,787,829 · 19 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $43M from 51 investors (100% of the $43M target) as of the latest filing. Paul is listed as director on 3 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Other Health Care / 506(b) (4,189 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

E
Other Health Care

ENDOTRONIX INC

Lisle, IL · Jul 19, 2016 → Dec 7, 2020 · 5 filings
  • Dec 7, 2020 · D/A · $69,277,224 sold of $90,787,992 · 38 investors · min. No minimum reported · role: Director EDGAR ↗
  • Oct 16, 2019 · D/A · $55,382,667 sold of $70,045,943 · 38 investors · min. No minimum reported · role: Director EDGAR ↗
  • Sep 28, 2018 · D · $20,250,169 sold of $45,000,111 · 31 investors · min. No minimum reported · role: Director EDGAR ↗
  • Feb 26, 2018 · D/A · $37,100,866 sold of $37,100,866 · 52 investors · min. No minimum reported · role: Director EDGAR ↗
  • Jul 19, 2016 · D · $18,951,250 sold of $37,000,000 · 51 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $69.3M from 52 investors (76% of the $90.8M target) as of the latest filing. Paul is listed as director on 5 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Other Health Care / 506(b) (4,189 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

BD
Other Health Care · group: Bardy

Bardy Diagnostics, Inc.

Seattle, WA · Oct 12, 2016 → Mar 31, 2020 · 6 filings
  • Mar 31, 2020 · D · $0 sold of $450,001 · 1 investors · min. No minimum reported · role: Director EDGAR ↗
  • Feb 28, 2020 · D · $12,492,818 sold of $13,000,000 · 28 investors · min. No minimum reported · role: Director EDGAR ↗
  • Apr 25, 2019 · D · $35,534,146 sold of $35,534,146 · 25 investors · min. No minimum reported · role: Director EDGAR ↗
  • Jan 3, 2019 · D · $6,000,000 sold of $6,250,000 · 10 investors · min. No minimum reported · role: Director EDGAR ↗
  • Jun 8, 2018 · D/A · $35,363,985 sold of $35,363,985 · 13 investors · min. No minimum reported · role: Director EDGAR ↗
  • Oct 12, 2016 · D · $27,613,967 sold of $27,613,967 · 10 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $35.5M from 28 investors (100% of the $450K target) as of the latest filing. Paul is listed as director on 6 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Other Health Care / 506(b) (4,189 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

MC
Pooled Investment Fund

Medtech Convergence Fund, L.P.

Boston, MA · Mar 12, 2019
  • Mar 12, 2019 · D · $0 sold of $94,000,000 · 0 investors · min. No minimum reported · role: Executive Officer (Managing Member of the General Partner) EDGAR ↗

No sales reported yet as of the latest filing. Paul is listed as executive officer.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pooled Investment Fund / 506(b) (83,801 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

V
Biotechnology

VALENTX INC

Maple Grove, MN · Jul 28, 2014 → Feb 19, 2019 · 4 filings
  • Feb 19, 2019 · D · $1,971,260 sold of $5,250,000 · 3 investors · min. No minimum reported · role: Director EDGAR ↗
  • Aug 16, 2018 · D · $10,271,050 sold of Indefinite · 32 investors · min. No minimum reported · role: Director EDGAR ↗
  • Sep 3, 2015 · D/A · $7,500,000 sold of $7,500,000 · 21 investors · min. No minimum reported · role: Director EDGAR ↗
  • Jul 28, 2014 · D · $4,111,767 sold of $7,500,000 · 20 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $20.3M from 32 investors (100% of the $5.25M target) as of the latest filing. Paul is listed as director on 4 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

AT
Other Technology

Axon Therapies Inc.

New York, NY · Apr 19, 2016 → Feb 7, 2019 · 4 filings
  • Feb 7, 2019 · D/A · $7,499,994 sold of $15,000,000 · 10 investors · min. No minimum reported · role: Director EDGAR ↗
  • Feb 7, 2019 · D · $74,999,993 sold of $150,000,000 · 10 investors · min. No minimum reported · role: Director EDGAR ↗
  • Jun 28, 2017 · D · $1,299,999 sold of $2,000,000 · 7 investors · min. No minimum reported · role: Director EDGAR ↗
  • Apr 19, 2016 · D · $2,000,000 sold of $2,000,000 · 1 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $75M from 10 investors (100% of the $15M target) as of the latest filing. Paul is listed as director on 4 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Other Technology / 506(b) (17,390 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

SS
Other Health Care

Soluble Systems LLC

Newport News, VA · Nov 9, 2017
  • Nov 9, 2017 · D · $19,000,000 sold of $28,250,000 · 2 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $19M from 72 investors (67% of the $28.3M target) as of the latest filing. Paul is listed as director.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Other Health Care / 506(b) (4,189 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

T
Other Health Care · group: Transenterix

TRANSENTERIX INC.

Morrisville, NC · Sep 12, 2013 → Sep 15, 2017 · 4 filings
  • Sep 15, 2017 · D · $950,000 sold of $950,000 · 1 investors · min. No minimum reported · role: Director EDGAR ↗
  • Sep 23, 2016 · D · $115,690 sold of $214,155 · 1 investors · min. No minimum reported · role: Director EDGAR ↗
  • Sep 17, 2013 · D · $160,372,455 sold of $160,372,455 · 43 investors · min. No minimum reported · role: Director EDGAR ↗
  • Sep 12, 2013 · D · $30,178,818 sold of $35,000,000 · 19 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $160.4M from 43 investors (100% of the $950K target) as of the latest filing. Paul is listed as director on 4 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Other Health Care / 506(b) (4,189 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

SL
Pooled Investment Fund · group: Sv Life Sciences

SV Life Sciences Fund VI Strategic Partners, L.P.

Boston, MA · Apr 12, 2017
  • Apr 12, 2017 · D · $13,130,000 sold of $13,130,000 · 35 investors · min. No minimum reported · role: Executive Officer EDGAR ↗

Raised $13.1M from 35 investors (100% of the $13.1M target) as of the latest filing. Paul is listed as executive officer.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pooled Investment Fund / 506(b) (83,801 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

DF
Other Health Care

Direct Flow Medical, Inc.

Santa Rosa, CA · Oct 1, 2009 → Jul 22, 2016 · 6 filings
  • Jul 22, 2016 · D/A · $27,100,143 sold of $32,300,000 · 11 investors · min. No minimum reported · role: Director EDGAR ↗
  • Apr 14, 2016 · D/A · $30,984,431 sold of $59,179,708 · 36 investors · min. No minimum reported · role: Director EDGAR ↗
  • Mar 31, 2016 · D · $15,081,184 sold of $21,500,000 · 7 investors · min. No minimum reported · role: Director EDGAR ↗
  • Dec 5, 2014 · D · $17,063,607 sold of $29,925,497 · 27 investors · min. No minimum reported · role: Director EDGAR ↗
  • Apr 17, 2012 · D/A · $40,284,325 sold of $42,500,001 · 18 investors · min. No minimum reported · role: Director EDGAR ↗
  • Oct 1, 2009 · D · $39,999,999 sold of $42,500,001 · 11 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $40.3M from 36 investors (100% of the $32.3M target) as of the latest filing. Paul is listed as director on 6 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Other Health Care / 506(b) (4,189 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

SL
Pooled Investment Fund · group: Sv Life Sciences

SV Life Sciences Fund VI, L.P.

Boston, MA · May 26, 2015 → May 26, 2016 · 2 filings
  • May 26, 2016 · D/A · $273,500,000 sold of $400,000,000 · 24 investors · min. No minimum reported · role: Executive Officer EDGAR ↗
  • May 26, 2015 · D · $0 sold of $400,000,000 · 0 investors · min. No minimum reported · role: Executive Officer EDGAR ↗

Raised $273.5M from 24 investors (68% of the $400M target) as of the latest filing. Paul is listed as executive officer on 2 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pooled Investment Fund / 506(b) (83,801 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

C
Other Health Care

CARDIOKINETIX INC

Menlo Park, CA · Sep 26, 2011 → Dec 9, 2014 · 2 filings
  • Dec 9, 2014 · D · $30,709,456 sold of $37,709,453 · 12 investors · min. No minimum reported · role: Director EDGAR ↗
  • Sep 26, 2011 · D · $24,557,849 sold of $44,757,840 · 17 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $30.7M from 17 investors (81% of the $37.7M target) as of the latest filing. Paul is listed as director on 2 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Other Health Care / 506(b) (4,189 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

BS
Other Health Care

BAXANO SURGICAL, INC.

Raleigh, NC · Jun 12, 2013 → Mar 26, 2014 · 3 filings
  • Mar 26, 2014 · D · $9,993,680 sold of $9,993,680 · 5 investors · min. No minimum reported · role: Director EDGAR ↗
  • Dec 17, 2013 · D · $1,200,000 sold of $1,200,000 · 1 investors · min. No minimum reported · role: Director EDGAR ↗
  • Jun 12, 2013 · D · $37,291,799 sold of $37,291,799 · 23 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $37.3M from 23 investors (100% of the $9.99M target) as of the latest filing. Paul is listed as director on 3 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Other Health Care / 506(b) (4,189 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

CH
Other Health Care

Cameron Health, Inc.

San Clemente, CA · May 20, 2011
  • May 20, 2011 · D · $82,670,840 sold of $107,178,246 · 62 investors · min. $1 · role: Director EDGAR ↗

Raised $82.7M from 62 investors (77% of the $107.2M target) as of the latest filing. Paul is listed as director.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer.

Other pages with the same name (1)

Separate person records under the same name, not combined with this page. Each line says whether it shares an issuer with this record.

  • Paul Laviolette — FL, 2 issuers, Sep 14, 2020 → Sep 15, 2020 · no shared issuer

People around Paul 40

Officers, directors, promoters and management entities named on the same filings, as of Oct 23, 2026, 5:45 PM ET. Showing the 40 with the most shared filings.

SL
Management entity

SV Life Sciences Fund VI (GP), L.P.

Executive Officer · 3 shared filings (2 issuers)

Listed on the same filings as Paul LaViolette. Their page shows their other deals.

SV
Management entity

SVLSF VI, LLC

Executive Officer · 3 shared filings (2 issuers)

Listed on the same filings as Paul LaViolette. Their page shows their other deals.

MC
Management entity

Medtech Convergence GP LLC

Executive Officer · 1 shared filing (1 issuer)

Listed on the same filings as Paul LaViolette. Their page shows their other deals.

BR
No photo found yet (own website and image search run after this page is viewed)
Person

Bruce Robertson

Director · 12 shared filings (2 issuers) · also on 5 other issuers

Bruce Robertson is on 7 issuers in total — a repeat sponsor. Their page lists every one.

GB
No photo found yet (own website and image search run after this page is viewed)
Person

Gerry Brunk

Director · 11 shared filings (3 issuers) · also on 2 other issuers

Gerry Brunk is on 5 issuers in total — a repeat sponsor. Their page lists every one.

CL
No photo found yet (own website and image search run after this page is viewed)
Person

Charles Larsen

Director · 10 shared filings (1 issuer) · also on 7 other issuers

Charles Larsen is on 8 issuers in total — a repeat sponsor. Their page lists every one.

CK
No photo found yet (own website and image search run after this page is viewed)
Person

CHRISTOPHER A. KROEGER

Director · 9 shared filings (1 issuer)

Listed on the same filings as Paul LaViolette. Their page shows their other deals.

OA
No photo found yet (own website and image search run after this page is viewed)
Person

Omar Amirana

Director · 9 shared filings (1 issuer) · also on 2 other issuers

Listed on the same filings as Paul LaViolette. Their page shows their other deals.

JG
No photo found yet (own website and image search run after this page is viewed)
Person

James Garvey

Director, Executive Officer · 9 shared filings (3 issuers) · also on 7 other issuers

James Garvey is on 10 issuers in total — a repeat sponsor. Their page lists every one.

PW
No photo found yet (own website and image search run after this page is viewed)
Person

PATRICK WETHINGTON

Director · 8 shared filings (2 issuers) · also on 2 other issuers

Listed on the same filings as Paul LaViolette. Their page shows their other deals.

GM
No photo found yet (own website and image search run after this page is viewed)
Person

GREG MADDEN

Director, Executive Officer · 8 shared filings (4 issuers) · also on 3 other issuers

GREG MADDEN is on 7 issuers in total — a repeat sponsor. Their page lists every one.

GB
No photo found yet (own website and image search run after this page is viewed)
Person

Gust H. Bardy

Director, Executive Officer, Promoter · 7 shared filings (2 issuers) · also on 1 other issuer

Listed on the same filings as Paul LaViolette. Their page shows their other deals.

GF
No photo found yet (own website and image search run after this page is viewed)
Person

GEORGE FAZIO

Executive Officer, Director · 7 shared filings (2 issuers) · also on 1 other issuer

Listed on the same filings as Paul LaViolette. Their page shows their other deals.

WC
No photo found yet (own website and image search run after this page is viewed)
Person

WARREN R. CLARK, III

Executive Officer · 7 shared filings (1 issuer)

Listed on the same filings as Paul LaViolette. Their page shows their other deals.

VO
No photo found yet (own website and image search run after this page is viewed)
Person

Vincent Owens

Director, Executive Officer · 7 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Paul LaViolette. Their page shows their other deals.

GB
No photo found yet (own website and image search run after this page is viewed)
Person

Gordon Bishop

Executive Officer, Director · 6 shared filings (1 issuer)

Listed on the same filings as Paul LaViolette. Their page shows their other deals.

MH
No photo found yet (own website and image search run after this page is viewed)
Person

Mark Handfelt

Executive Officer, Promoter · 6 shared filings (1 issuer) · also on 2 other issuers

Listed on the same filings as Paul LaViolette. Their page shows their other deals.

DM
No photo found yet (own website and image search run after this page is viewed)
Person

David Milne

Director, Executive Officer · 6 shared filings (2 issuers) · also on 11 other issuers

David Milne is on 13 issuers in total — a repeat sponsor. Their page lists every one.

BB
No photo found yet (own website and image search run after this page is viewed)
Person

BURKE BARRETT

Executive Officer, Director · 6 shared filings (1 issuer)

Listed on the same filings as Paul LaViolette. Their page shows their other deals.

DT
No photo found yet (own website and image search run after this page is viewed)
Person

David Tamburri

Director · 6 shared filings (1 issuer)

Listed on the same filings as Paul LaViolette. Their page shows their other deals.

WW
No photo found yet (own website and image search run after this page is viewed)
Person

Warren Watson

Director · 6 shared filings (2 issuers)

Listed on the same filings as Paul LaViolette. Their page shows their other deals.

TS
No photo found yet (own website and image search run after this page is viewed)
Person

Thomas Snead

Director, Executive Officer · 6 shared filings (2 issuers) · also on 1 other issuer

Listed on the same filings as Paul LaViolette. Their page shows their other deals.

RZ
No photo found yet (own website and image search run after this page is viewed)
Person

Robert Zieserl

Director · 5 shared filings (1 issuer) · also on 3 other issuers

Listed on the same filings as Paul LaViolette. Their page shows their other deals.

MG
No photo found yet (own website and image search run after this page is viewed)
Person

Marc Goldberg

Director · 5 shared filings (1 issuer) · also on 9 other issuers

Marc Goldberg is on 10 issuers in total — a repeat sponsor. Their page lists every one.

JD
No photo found yet (own website and image search run after this page is viewed)
Person

Jeani Delagardelle

Director · 5 shared filings (2 issuers) · also on 5 other issuers

Jeani Delagardelle is on 7 issuers in total — a repeat sponsor. Their page lists every one.

AL
No photo found yet (own website and image search run after this page is viewed)
Person

Alan Levy

Director · 5 shared filings (1 issuer) · also on 4 other issuers

Alan Levy is on 5 issuers in total — a repeat sponsor. Their page lists every one.

RK
No photo found yet (own website and image search run after this page is viewed)
Person

Richard Kent

Director · 5 shared filings (1 issuer) · also on 6 other issuers

Richard Kent is on 7 issuers in total — a repeat sponsor. Their page lists every one.

JH
No photo found yet (own website and image search run after this page is viewed)
Person

James J. Hummer

Director · 5 shared filings (1 issuer)

Listed on the same filings as Paul LaViolette. Their page shows their other deals.

HR
No photo found yet (own website and image search run after this page is viewed)
Person

Harry Rowland

Executive Officer, Director · 5 shared filings (1 issuer)

Listed on the same filings as Paul LaViolette. Their page shows their other deals.

TM
No photo found yet (own website and image search run after this page is viewed)
Person

Tracy Marshbanks

Director · 5 shared filings (1 issuer)

Listed on the same filings as Paul LaViolette. Their page shows their other deals.

DC
No photo found yet (own website and image search run after this page is viewed)
Person

David S. Celermajer

Director · 5 shared filings (1 issuer)

Listed on the same filings as Paul LaViolette. Their page shows their other deals.

HL
No photo found yet (own website and image search run after this page is viewed)
Person

Howard R. Levin

Executive Officer, Director · 5 shared filings (2 issuers)

Listed on the same filings as Paul LaViolette. Their page shows their other deals.

MQ
No photo found yet (own website and image search run after this page is viewed)
Person

Mark Querry

Executive Officer · 5 shared filings (1 issuer)

Listed on the same filings as Paul LaViolette. Their page shows their other deals.

TB
No photo found yet (own website and image search run after this page is viewed)
Person

Tara Butler

Director · 4 shared filings (1 issuer) · also on 11 other issuers

Tara Butler is on 12 issuers in total — a repeat sponsor. Their page lists every one.

BG
No photo found yet (own website and image search run after this page is viewed)
Person

BOBBY I. GRIFFIN

Director · 4 shared filings (1 issuer) · also on 3 other issuers

Listed on the same filings as Paul LaViolette. Their page shows their other deals.

RP
No photo found yet (own website and image search run after this page is viewed)
Person

Richard C. Pfenniger, Jr.

Director · 4 shared filings (1 issuer) · also on 3 other issuers

Listed on the same filings as Paul LaViolette. Their page shows their other deals.

EH
No photo found yet (own website and image search run after this page is viewed)
Person

Eugene D. Hill

Executive Officer · 4 shared filings (3 issuers) · also on 8 other issuers

Eugene D. Hill is on 11 issuers in total — a repeat sponsor. Their page lists every one.

WS
No photo found yet (own website and image search run after this page is viewed)
Person

William N. Starling

Director · 4 shared filings (1 issuer) · also on 10 other issuers

William N. Starling is on 11 issuers in total — a repeat sponsor. Their page lists every one.

MB
No photo found yet (own website and image search run after this page is viewed)
Person

Mitchell S. Bloom

Executive Officer · 4 shared filings (1 issuer) · also on 11 other issuers

Mitchell S. Bloom is on 12 issuers in total — a repeat sponsor. Their page lists every one.

The team behind the deals

SL
Sponsor group

Sv Life Sciences

10 issuers · 16 filings · $1.56B reported sold · 2010–2026

One team, 10 deal companies. Paul LaViolette is listed on 3 of them.

Sources

Issuers are grouped when their Form D filings share related persons, a management entity or a business address (automatic match from the filings). "Listed" marks the issuers that name Paul LaViolette.

B
Sponsor group

Bardy

2 issuers · 7 filings · $10.5M reported sold · 2016–2025

One team, 2 deal companies. Paul LaViolette is listed on 1 of them.

Sources

Issuers are grouped when their Form D filings share related persons, a management entity or a business address (automatic match from the filings). "Listed" marks the issuers that name Paul LaViolette.

T
Sponsor group

Transenterix

2 issuers · 12 filings · $2.95M reported sold · 2009–2017

One team, 2 deal companies. Paul LaViolette is listed on 1 of them.

Sources

Issuers are grouped when their Form D filings share related persons, a management entity or a business address (automatic match from the filings). "Listed" marks the issuers that name Paul LaViolette.

Same business address

51 other issuers file from the same address (first 50 shown)

A shared address can mean the same team, a shared office building or a registered agent. It is a lead, not a conclusion.

Registrations and other filings

Business registration (state registry / Secretary of State)

Individuals are not matched to business registrations — registries list companies, and a name alone is not enough to tie a person to one. Officers and managers appear by name inside each matched company's record on the issuer pages. Registries searched: AL (Alabama Secretary of State — Business Entity Records (arc-sos.state.al.us), searched by issuer name, data as of Oct 24, 2026); CO (Colorado Secretary of State — Business Entities in Colorado (data.colorado.gov), data as of Oct 23, 2026); CT (Connecticut Secretary of the State — Business Registry (data.ct.gov), data as of Oct 24, 2026); FL (Florida Department of State, Division of Corporations — quarterly corporate data file (Sunbiz), data as of Oct 7, 2026); NY (New York Department of State — Corporations and Other Entities (data.ny.gov: All Filings + Active Corporations), data as of Oct 20, 2026); OR (Oregon Secretary of State — Active Businesses, All (data.oregon.gov), data as of Oct 20, 2026); PA (Pennsylvania Department of State — Registered Businesses, Current (data.pa.gov), data as of Oct 6, 2026); TX (Texas Comptroller — Active Franchise Taxpayers incl. Secretary of State file data (data.texas.gov), data as of Oct 24, 2026). Registries of other states have not been searched: many publish no bulk file and require a CAPTCHA or bot challenge on their search page, which we do not bypass (Delaware, for example, offers no public bulk file).

Adviser registration (Form ADV)

None of the 20 issuers this person is listed on appears in Form ADV (searched 24,962 advisers as of Oct 2, 2026). A person is never an adviser firm; Form ADV is checked for the issuers and the management companies they are listed with.

Other offering types (Regulation A and Regulation Crowdfunding)

Searched SEC Regulation A Data Sets (Forms 1-A, 1-K, 1-Z; 2015 Q2 → 2026 Q3); SEC Crowdfunding Offerings Data Sets (Form C family; 2016 Q2 → 2026 Q3); EDGAR form index for 2026 Q3 → 2026 Q4 (51,358 records as of Oct 23, 2026, 8:41 PM ET) — nothing matched this name.

Property records none — individuals are not matched

Property records are matched to companies only, never to individuals, so none are matched to Paul LaViolette by design. Searched property records in Hillsborough County FL (Clerk recorded-document index Oct 14, 2026 to Oct 15, 2026 + FL DOR 2026 ownership roll), Miami-Dade County FL (FL DOR 2026 ownership roll), Harris County TX (HCAD 2026 ownership roll), Dallas County TX (DCAD 2026 ownership roll), New York City ACRIS documents and PLUTO ownership rows already retrieved for other issuers, Cook County IL sale and ownership rows already retrieved for other issuers (814,874 records as of Oct 23, 2026, 8:59 PM ET) for the 20 issuers this person is listed on — nothing matched.

Public profiles and social

Websites and social links of the issuers Paul LaViolette is listed on: none on file. No website or social profile named in SV Life Sciences Fund IV CF, L.P.'s SEC filings (Form C, Reg A, Form ADV; checked Oct 24, 2026). Web search for this name: #160,529 of 374,652 in line (1,386 issuers searched so far). One-tap searches: Look further ↓

Look further

One-tap searches on sites we do not index ourselves, with the name pre-filled (Boston, MA). Each opens in a new tab; what you find there is not verified by PartnerFacts.

Social and web

LinkedIn people search ↗Instagram ↗X (Twitter) ↗Facebook ↗YouTube ↗Google ↗Google Images ↗Google News ↗Meta Ad Library ↗

Courts

CourtListener / RECAP (federal) ↗PACER case locator (federal, login) ↗California — find the county court ↗Los Angeles Superior Court case search ↗Massachusetts MassCourts ↗North Carolina eCourts portal ↗Hillsborough County FL Clerk (HOVER) ↗Miami-Dade Clerk online case search ↗Maryland Judiciary case search ↗Minnesota court records online ↗New York WebCivil Supreme ↗Cook County Clerk of Court case search ↗Virginia state courts — find the court ↗Washington Courts case search (dw.courts.wa.gov) ↗

Securities regulators

SEC EDGAR full-text search ↗SEC action look-up ↗FINRA BrokerCheck ↗SEC IAPD adviser search ↗

Business registries

California Secretary of State business search ↗Massachusetts Secretary of State business search ↗North Carolina Secretary of State business search ↗Florida Secretary of State business search ↗Maryland Secretary of State business search ↗Minnesota Secretary of State business search ↗New York Secretary of State business search ↗Illinois Secretary of State business search ↗Virginia Secretary of State business search ↗Washington Secretary of State business search ↗OpenCorporates ↗

Change history

No corrections have been requested for this page.

Every fact links to its public-record source. Plain-English notes next to a fact are our reading of that fact, not a rating. Request a correction · Facts policy

Request a correction

Free. Logged with status: received → under review → fixed / confirmed with source.

Add a response

If this is you or your firm, add a sourced explanation next to any fact. Reviewed before publishing.

Monitor this person

Members get an email when Paul LaViolette appears on a new Form D, or when a court case or SEC action is matched to them. See plans →